Logo image of LQDA

LIQUIDIA CORP (LQDA) Stock Price, Quote, News and Overview

NASDAQ:LQDA - Nasdaq - US53635D2027 - Common Stock - Currency: USD

13.1  +0.27 (+2.1%)

After market: 13.1 0 (0%)

LQDA Quote, Performance and Key Statistics

LIQUIDIA CORP

NASDAQ:LQDA (6/27/2025, 8:00:00 PM)

After market: 13.1 0 (0%)

13.1

+0.27 (+2.1%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High19.41
52 Week Low8.26
Market Cap1.12B
Shares85.48M
Float72.03M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-05 2025-08-05/amc
IPO07-26 2018-07-26


LQDA short term performance overview.The bars show the price performance of LQDA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10

LQDA long term performance overview.The bars show the price performance of LQDA in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200

The current stock price of LQDA is 13.1 USD. In the past month the price decreased by -12.67%. In the past year, price increased by 9.17%.

LIQUIDIA CORP / LQDA Daily stock chart

LQDA Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 56.36 734.92B
JNJ JOHNSON & JOHNSON 15.17 366.71B
NVO NOVO-NORDISK A/S-SPONS ADR 18.57 304.42B
NVS NOVARTIS AG-SPONSORED ADR 14.44 237.03B
AZN ASTRAZENECA PLC-SPONS ADR 15.87 216.57B
MRK MERCK & CO. INC. 10.15 198.62B
PFE PFIZER INC 7.54 137.53B
SNY SANOFI-ADR 10.49 116.45B
BMY BRISTOL-MYERS SQUIBB CO 6.31 94.33B
GSK GSK PLC-SPON ADR 8.54 78.19B
ZTS ZOETIS INC 25.94 69.53B
TAK TAKEDA PHARMACEUTIC-SP ADR 62.92 47.17B

About LQDA

Company Profile

LQDA logo image Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. The company is headquartered in Morrisville, North Carolina and currently employs 157 full-time employees. The company went IPO on 2018-07-26. The firm is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The firm operate through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.

Company Info

LIQUIDIA CORP

419 Davis Drive, Suite 100

Morrisville NORTH CAROLINA 27560 US

CEO: Neal Fowler

Employees: 145

LQDA Company Website

LQDA Investor Relations

Phone: 19193284400

LIQUIDIA CORP / LQDA FAQ

What is the stock price of LIQUIDIA CORP today?

The current stock price of LQDA is 13.1 USD. The price increased by 2.1% in the last trading session.


What is the ticker symbol for LIQUIDIA CORP stock?

The exchange symbol of LIQUIDIA CORP is LQDA and it is listed on the Nasdaq exchange.


On which exchange is LQDA stock listed?

LQDA stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for LIQUIDIA CORP stock?

16 analysts have analysed LQDA and the average price target is 31.42 USD. This implies a price increase of 139.82% is expected in the next year compared to the current price of 13.1. Check the LIQUIDIA CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LIQUIDIA CORP worth?

LIQUIDIA CORP (LQDA) has a market capitalization of 1.12B USD. This makes LQDA a Small Cap stock.


How many employees does LIQUIDIA CORP have?

LIQUIDIA CORP (LQDA) currently has 145 employees.


What are the support and resistance levels for LIQUIDIA CORP (LQDA) stock?

LIQUIDIA CORP (LQDA) has a support level at 13.09 and a resistance level at 13.79. Check the full technical report for a detailed analysis of LQDA support and resistance levels.


Is LIQUIDIA CORP (LQDA) expected to grow?

The Revenue of LIQUIDIA CORP (LQDA) is expected to grow by 146.53% in the next year. Check the estimates tab for more information on the LQDA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LIQUIDIA CORP (LQDA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LIQUIDIA CORP (LQDA) stock pay dividends?

LQDA does not pay a dividend.


When does LIQUIDIA CORP (LQDA) report earnings?

LIQUIDIA CORP (LQDA) will report earnings on 2025-08-05, after the market close.


What is the Price/Earnings (PE) ratio of LIQUIDIA CORP (LQDA)?

LIQUIDIA CORP (LQDA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.58).


What is the Short Interest ratio of LIQUIDIA CORP (LQDA) stock?

The outstanding short interest for LIQUIDIA CORP (LQDA) is 23.03% of its float. Check the ownership tab for more information on the LQDA short interest.


LQDA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

LQDA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to LQDA. LQDA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LQDA Financial Highlights

Over the last trailing twelve months LQDA reported a non-GAAP Earnings per Share(EPS) of -1.58. The EPS decreased by -1.28% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -56.21%
ROE -257.14%
Debt/Equity 2.08
Chartmill High Growth Momentum
EPS Q2Q%16.67%
Sales Q2Q%4.98%
EPS 1Y (TTM)-1.28%
Revenue 1Y (TTM)-11.45%

LQDA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to LQDA. The Buy consensus is the average rating of analysts ratings from 16 analysts.

For the next year, analysts expect an EPS growth of -3.89% and a revenue growth 146.53% for LQDA


Ownership
Inst Owners63.22%
Ins Owners3.74%
Short Float %23.03%
Short Ratio7.91
Analysts
Analysts82.5
Price Target31.42 (139.85%)
EPS Next Y-3.89%
Revenue Next Year146.53%